Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 1 of 16 PageID #: 9144
`Case 1:14—cv—OO113—RGA—MPT Document 273-3 Filed 09/21/15 Page 1 of 16 Page|D #: 9144
`
`
`
`
`
`TAB C
`
`TAB C
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 2 of 16 PageID #: 9145
`
`Mohan P. Rao, Ph.D.
`Managing Director
`
`Epsilon Economics
`111 South Wacker Drive, 50th Floor
`Chicago, Illinois 60606
`
`Summary
`
`Direct: 312.637.2980
`Main: 312.637.2950
`Fax: 312.637.2951
`mrao@epsiloneconomics.com
`
`Dr. Rao is a Managing Director at Epsilon Economics and an Adjunct Professor in the De-
`partment of Industrial Engineering and Management Sciences at Northwestern University.
`He specializes in antitrust, intellectual property, and financial economics.
`
`Dr. Rao has provided economic analysis in antitrust litigation, including in cases involving
`monopolization, price fixing, and bid rigging, as well as the interplay between antitrust and
`intellectual property. His intellectual property experience includes valuing patents, trade-
`marks, and trade secrets across a wide range of industries, including computers, information
`technology, manufacturing, utilities, consumer products, aviation, chemicals, and pharma-
`ceuticals. He has experience in valuing early stage technologies in the pharmaceutical and
`biotechnology industries. He has studied market structure, competition, and performance
`of numerous pharmaceutical products, including pricing, marketing and promotion, clinical
`trials and regulatory approval. He has evaluated commercial success of patented products,
`including in ANDA actions. Dr. Rao has served as an economics expert in U.S. and foreign
`courts and in U.S. and international arbitration proceedings.
`
`Dr. Rao teaches finance at Northwestern University and previously taught at UCLA. He
`also teaches courses on valuing intellectual property at the Licensing Executives Society,
`where he served as the Chair of the Valuation and Taxation Committee.
`
`Dr. Rao is a partner of Expression Therapeutics LLC, a biotechnology firm focused on
`advanced therapies for treating hemophilia. He serves on the Board of Directors of the
`Children’s Hospital of Chicago and the Stanley Manne Children’s Research Institute, on
`the Board of Trustees of the Rotary/One Foundation, and is a member of the Economic
`Club of Chicago.
`
`6/7/2015
`
`Page 1 of 15
`
`DTX-0388
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 3 of 16 PageID #: 9146
`
`Academic and Professional Experience
`
`• Epsilon Economics
`Managing Director, 2015-present
`• Navigant Economics
`Managing Director, 2010–2015
`• LECG
`Managing Director, 2005–2010
`• Northwestern University
`McCormick School of Engineering and Applied Science
`Adjunct Professor, 2006–present
`• Charles River Associates / InteCap, Inc.
`Vice President, CRA, 2004–2005
`Managing Director, InteCap, 2004–2005
`Director, InteCap, 2000–2003
`• University of California, Los Angeles
`Assistant Professor, 1994–2001
`• Harvard University
`Fellow, Government Data Center, 1993–1994
`Teaching Fellow, 1993–1994
`
`Education
`
`• B.S. (Engineering), 1989, University of Michigan
`• Pre-Doctoral Fellow, 1993–1994, Harvard University
`• Ph.D.; M.A. (Economics; Int’l Relations), 1994, University of Colorado
`
`Selected Fellowships and Awards
`
`• Cooley Award, University of Michigan College of Engineering
`• Government Data Center Fellowship, Harvard University
`• David Cattell Fellowship, UCLA
`
`6/7/2015
`
`Page 2 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 4 of 16 PageID #: 9147
`
`• Faculty Career Development Award, UCLA
`
`Selected Affiliations
`
`• Member, American Economic Association
`• Member, Licensing Executives Society
`• Member, Institute of Electrical and Electronics Engineers (IEEE)
`
`Expert Testimony
`
`1. Lavastone Capital LLC v. Coventry First LLC, et al.
`U.S. District Court — Southern District of New York
`C.A. No.: 14-CV-7139
`
`2. Pericor Therapeutics v. Merck & Co., Inc.
`American Arbitration Association
`AAA Arbitration No. 13 122 J03052
`
`3. Lufkin Industries, Inc. v. International Business Machines et al.
`District Court — Angelina County, Texas
`Case No.: cv-02073-13-02
`
`4. Sunovion Pharmaceuticals Inc. v. Takeda GMBH
`International Court of Arbitration
`ICC Case No. 19231/GFG
`
`5. LG Household and Health Care Limited v. Akinari Ikka and Eri Ikka
`International Court of Arbitration
`ICC Arbitration No. 19421/CYK
`
`6. Mirowski Family Ventures, LLC. v. Boston Scientific Corp. et al.
`Circuit Court — Montgomery County, Maryland (Judge Ronald B. Rubin)
`Civil No. 373798-V
`
`7. Dell Inc. et al v. Hitachi, Ltd. et al.
`U.S. District Court — Northern District of California (San Francisco Division)
`Case No.: 3:13-cv-02171-SC
`
`8. Purdue Pharma L.P. et al v. Amneal Pharmaceuticals, LLC, Teva Phar-
`maceuticals USA, Inc.
`
`6/7/2015
`
`Page 3 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 5 of 16 PageID #: 9148
`
`U.S. District Court — Southern District of New York (Judge Stine)
`Case No. 13-cv-3372 (SHS)
`Case No. 13-cv-4606 (SHS)
`
`9. Gilead Sciences, Inc. and Emory University v. Cipla Limited
`U.S. District Court — Southern District of New York
`Civil Action No. 12-CIV-6350 (RJS) (AJP)
`Civil Action No. 12-CV-6351 (RJS) (AJP)
`
`10. Gilead Sciences, Inc. and Emory University v. Lupin Limited
`U.S. District Court — Southern District of New York
`Civil Action No. 12-CIV-6293 (RJS) (AJP)
`Civil Action No. 12-CV-6294 (RJS) (AJP)
`
`11. Galderma Laboratories, L.P. et al v. Actavis Mid Atlantic LLC
`U.S. District Court — Northern District of Texas
`3:12-CV-2038
`
`12. MPEG LA, L.L.C. v. Dell Global B.V. and Dell Products, L.P.
`Court of Chancery — The State of Delaware
`C.A. No. 7016-VCP
`
`13. Source Healthcare Analytics, Inc., Wolters Kluwer U.S. Corporation
`et al. v. SDI Health LLC et al.
`Court of Common Pleas — Philadelphia County (Commerce Court Program)
`No. 02290
`
`14. United States of America ex rel. Donald Gale v. Omnicare, Inc.
`U.S. District Court — Northern District of Ohio (Eastern Division)
`Case No. 1:10 CV-0127
`
`15. Scienton Technologies, Inc. v. Computer Associates International, Inc.
`U.S. District Court — Eastern District of New York
`Case No. 04-CV-2652 (JS)(ETB)
`
`16. In re Oxycontin Antitrust Litigation
`U.S. District Court — Southern District of New York (Judge Stine)
`Case No. 04-md-1603 (SHS)
`
`17. Avid Technology, Inc. v. Harmonic Inc.
`U.S. District Court — District of Delaware
`Civil Action No. 1:11 CV-01040-GMS-SRF
`
`18. Gilead Sciences, Inc. v. Sigmapharm Laboratories, LLC
`U.S. District Court — District of New Jersey
`
`6/7/2015
`
`Page 4 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 6 of 16 PageID #: 9149
`
`C.A. No. 10-CV-4931 (SDW) (MCA)
`
`19. Bayer Healthcare LLC v. Pfizer Inc.
`U.S. District Court — Northern District of Illinois
`Civil Action No. 1:12-cv-00630
`
`20. Kimberly-Clark Corporation v. Cardinal Health 200, LLC et al.
`U.S. District Court — Northern District of Georgia (Atlanta Division)
`Civil Action No. 1:10 CV-0034-CAP
`
`21. Multimedia Patent Trust v. Apple Inc., LG Electronics, Inc. et al.
`U.S. District Court — Southern District of California
`Case No. 10-CV-2618 JLS RBB
`
`22. The Swatch Group Ltd. et al. v. Tiffany and Company et al.
`Netherlands Arbitration Institute
`NAI Case No. 3905
`
`23. Boston Scientific Corporation et al. v. Mirowski Family Ventures, LLC.
`U.S. District Court — Southern District of Indiana (Indianapolis Division)
`Civil Action No. 1:11-cv-0736WTL DKL
`
`24. Tyco Healthcare Group LP et al. v. Pharmaceutical Holdings Corp. et al.
`U.S. District Court — District of New Jersey
`C.A. No. 07-cv-1299 (SRC)(MAS)
`
`25. Teva Neuroscience, Inc., et al. v. Watson Laboratories, Inc., et al.
`U.S. District Court — District of New Jersey
`C.A. No. 2:10-cv-05078 (CCC) (JAD); C.A. No. 2:11-cv-03076 (CCC) (JAD)
`
`26. PSN Illinois, LLC. v. Abbott Laboratories, Inc. and Abbott Bioresearch
`Center, Inc.
`U.S. District Court — Northern District of Illinois (Eastern Division)
`Case No. 09-cv-05879
`
`27. Hoffman-La Roche Inc. v. Teva Pharmaceuticals USA, Inc. et al.
`U.S. District Court — New Jersey
`Civ. Action No. 2:09-cv-05283; Civ. Action No. 2:09-cv-06335
`
`28. Aria Diagnostics, Inc. v. Sequenom, Inc.
`U.S. District Court — Northern District of California
`Case No. 3:11-cv-06391-SI
`
`29. In re TFT-LCD (Flat Panel) Antitrust Litigation
`On behalf of: Dell Inc. and Dell Products L.P.
`
`6/7/2015
`
`Page 5 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 7 of 16 PageID #: 9150
`
`U.S. District Court – Northern District of California (San Francisco Division)
`Case No. 10 1064
`
`30. MPEG-LA, L.L.C. v. Audiovox Electronics Corporation et al.
`Supreme Court of the State of New York — County of Suffolk (Judge Emily
`Pines)
`Index No. 24678/08
`
`31. Genzyme Corporation v. Seikagaku Corporation, Zimmer Holdings, Inc.
`et al.
`U.S. District Court — District of Massachusetts (Judge Douglas P. Woodlock)
`C.A. NO.: 1:11-cv-1-636-DPW
`
`32. Rembrandt Vision Technologies, LP et al. v. Bausch & Lomb, Inc.
`American Arbitration Association
`Case No. 14 122 Y 00403 09
`
`33. DSM Desotech Inc. v. 3D Systems Corporation and 3D Systems, Inc.
`U.S. District Court — Northern District of Illinois (Eastern Division)
`Civil Case No. 08 C 1531
`
`34. Onyx Pharmaceuticals, Inc. v. Bayer Corporation et al.
`U.S. District Court — Northern District of California
`Case No. 3:09-cv-02145-MHP
`
`35. Sanofi-Aventis Deutschland GMBH et al. v. Glenmark Pharmaceuticals
`Inc., USA, et al.
`U.S. District Court – District of New Jersey (Judge Dennis M. Cavanaugh)
`C.A. No. 07-CV-05855 (DMC-JAD)
`
`36. Advanced Stent Technologies, Inc. v. Boston Scientific Corporation
`American Arbitration Association
`Case Nos. 65 180 Y 00290 08 and 65 489 00292 08
`
`37. Jayhawk Capital Management LLC, et al. v. LSB Industries, Inc., et al.
`U.S. District Court – District of Kansas
`Case No.: 08-CV-2561 EFM/JPO
`
`38. Ortho-McNeil-Janssen Pharmaceuticals, Inc. et al. v. Watson Laboratories,
`Inc., Sandoz, Inc., Lupin Pharmaceuticals, Inc. et al.
`U.S. District Court – District of New Jersey
`Civil No.: 08-5103 (SRC)(MAS)
`
`39. Bristol-Myers Squibb Company (U.S.A.) v. Daiichi Sankyo Company
`Limited (Japan)
`
`6/7/2015
`
`Page 6 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 8 of 16 PageID #: 9151
`
`International Court of Arbitration
`ICC Case No. 15564/EC/VRO
`
`40. Bayer Healthcare Pharmaceuticals, Inc. v. Schering Corporation
`Court of Chancery of the State of Delaware
`C.A. No. 3548-VCS
`
`41. LG Electronics U.S.A., Inc. et al. v. Whirlpool Corporation et al.
`U.S. District Court – District of Delaware (Judge Gregory M. Sleet)
`Civil Action No.: 08-CV-234
`
`42. Microsoft Corporation v. Franchise Tax Board
`Superior Court of the State of California – For the County of San Francisco
`Case No.: CGC 08-471260
`
`43. Securities and Exchange Commission v. Biovail Corporation et al.
`On behalf of: John Miszuk
`U.S. District Court – Southern District of New York
`Civil Action No.: 08 Civ. 02979(LAK)
`
`44. Claredi Corporation v. SeeBeyond Technology Corporation
`U.S. District Court – Eastern District of Missouri (Eastern Division)
`Civil Action No.: 4:04-CV-1304RWS
`
`45. LG Electronics U.S.A., Inc. v. Whirlpool Corporation
`U.S. District Court – Northern District of Illinois (Eastern District)
`Civil Action No.: 08 C 242
`
`46. Unigene Laboratories, Inc. et al. v. Apotex, Inc. et al.
`U.S. District Court – Southern District of New York
`Civil Action No.: 06-CV-5571
`
`47. Sanofi-Aventis Canada Inc. et al. v. Novopharm Limited
`Federal Court of Canada – Toronto
`Court File No. T-1161-07 Dated December 5, 2007
`
`48. 3M Company et al. v. Moldex-Metric, Inc.
`U.S. District Court – District of Minnesota
`Civil Action No.: 03-CV-5292 (MJD/AJB)
`
`49. Boehringer Ingelheim Pharmaceuticals, Inc. v. Abbott Laboratories et al.
`Private Arbitration — Chicago, Illinois
`
`50. Thomas Johnson v. Clark/McHugh/Rausch and Walsh/Riteway
`Circuit Court of Cook County, Illinois (County Department, Law Division)
`
`6/7/2015
`
`Page 7 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 9 of 16 PageID #: 9152
`
`Case No.: 03 L 015015
`
`51. Aventis Pharma S.A. v. Baxter Healthcare Corporation
`The International Institute for Conflict Prevention and Resolution
`CPR File: G-08-05
`
`52. In re K-DUR Antitrust Litigation
`On behalf of: Schering-Plough Corporation
`U.S. District Court – District of New Jersey
`Civil Action No.: 01-1652 (JAG); MDL Docket No. 1419
`
`53. The Procter & Gamble Company v. Ultreo, Inc.
`U.S. District Court – Southern District of New York
`Civil Action No. 07 CIV 8379 (HB) (Judge Richard Sullivan)
`
`54. Church & Dwight Co., Inc. v. Abbott Laboratories
`U.S. District Court – District of New Jersey
`Civil Action No. 05 CV 2142 (GEB) (Judge Garrett E. Brown)
`
`55. Boehringer Ingelheim International GmbH and Boehringer Ingelheim
`Pharmaceuticals, Inc. v. Barr Laboratories Inc.
`U.S. District Court – District of Delaware
`C.A. No. 05-700-(KAJ) (Judge Joseph J. Farnan, Jr.)
`
`56. The Dow Chemical Company v. Shell Oil Company
`Circuit Court of Cook County, Illinois (County Department, Law Division)
`Civil Action No.: 00L13873
`
`57. Fresenius Medical Care Holdings, Inc. and Nabi Biopharmaceuticals, Inc. v.
`Roxane Laboratories, Inc.
`U.S. District Court – Southern District of Ohio (Eastern Division)
`Case No.: C2 05 889
`
`58. Dyson Technology Limited and Dyson, Inc. v. Maytag Corporation
`U.S. District Court – District of Delaware
`Civil Action No.: 05-434-GMS
`
`59. Casmier Bobak and Jeanette Bobak v. The City of Chicago et al.
`Circuit Court of Cook County, Illinois (County Department, Law Division)
`Case No.: 02 L 6981
`
`60. Shuffle Master, Inc. v. Yehia Awada and Gaming Entertainment, Inc.
`U.S. District Court – Northern District of Illinois (Eastern Division)
`Case No.: CV-S-05-1112-RCJ-RJJ
`
`6/7/2015
`
`Page 8 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 10 of 16 PageID #:
` 9153
`
`61. Schering-Plough, Ltd. v. Centocor, Inc.
`American Arbitration Association
`AAA No.: 50 181 T 00350 05 (Judge Edward N. Cahn)
`
`62. Christopher Boyle et al. v. Advanced Bio Prosthetic Surfaces, Ltd.,
`ABPS Management, L.L.C., et al.
`American Arbitration Association
`AAA No.: 70 180 Y 00655 04
`
`63. Diodem, LLC v. Biolase Technology, Inc. et al.
`U.S. District Court – Central Division of California (Western Division)
`CV-03-2142 GAF (RCx)
`
`64. Federal Trade Commission v. Mercury Marketing of Delaware, Inc. et al.
`On behalf of: Mercantile Capital LLC
`U.S. District Court – Eastern District of Pennsylvania
`C.A. No. 00-CV-3281 (Judge Clifford Scott Green)
`
`65. Pfizer, Inc., Warner Lambert Company et al. v. Ranbaxy Laboratories
`Limited et al.
`U.S. District Court – District of Delaware
`Case No.: 03-209-JJF (Judge Joseph J. Farnan, Jr.)
`
`66. ATI Systems, Inc. v. PECO Energy Company
`American Arbitration Association
`AAA No.: 14 117 00892 03 (Judge John J. Gibbons)
`
`67. In re Relafen Antitrust Litigation
`Eon Labs, Inc. v. GlaxoSmithKline PLC et al.
`U.S. District Court – District of Massachusetts
`Master File No.: 01-12239-WGY; Civil Action No.: 03-10506-WGY
`
`Preprints and Publications
`
`1. “Innovation Markets,” Market Definition in Antitrust: Theory and Case Stud-
`ies, American Bar Association, 2012, Chapter XIII (with Robert Maness).
`
`2. “The Demise of the 25% Rule,” Intellectual Asset Management, May/June 2011
`(with Jonathan Tomlin).
`
`3. “25 Percent Rule Rest in Peace,” Viewpoints, Vol. XVIII No. 2, April 2011.
`
`6/7/2015
`
`Page 9 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 11 of 16 PageID #:
` 9154
`
`4. “Valuing Intellectual Property in Licensing Transactions,” The Licensing Jour-
`nal , June/July 2008.
`
`5. “Economic Analysis in Securities Class Certifications,” Litigation Services Hand-
`book: The Role of the Financial Expert, 2008 Supplement, Roman L. Weil,
`Michael J. Wagner, and Peter B. Frank, Editors, New York: John Wiley, 2008
`(with Cathy M. Niden).
`
`6. “Econometric Analysis,” Litigation Services Handbook: The Role of the Finan-
`cial Expert, Fourth Edition, Roman L. Weil, Michael J. Wagner, and Peter B.
`Frank, Editors, New York: John Wiley, 2007 (with Christian Tregillis).
`
`7. “A Primer on Trademarks and Trademark Valuation,” Economic Damages in
`Intellectual Property, Daniel Slottje, Editor, New York: John Wiley, 2006 (with
`Michaelyn Corbett and David Teece).
`
`8. “What Experts Should Fear Most,” Expert Alert, Vol. 1, No. 1, Winter 2005,
`American Bar Association (with John Bone).
`
`9. “Econometric Analysis,” Litigation Services Handbook: The Role of the Finan-
`cial Expert, 2003 Supplement, Roman L. Weil, Michael J. Wagner, and Peter
`B. Frank, Editors, New York: John Wiley, 2004 (with Christian Tregillis).
`
`10. “Inferring Micro– from Macrolevel Change: Ecological Panel Inference in Sur-
`veys.” Working Paper, UCLA and New York University, 2001 (with Alexander
`A. Schuessler).
`
`11. “The Dynamics of the Democratic Peace,” Journal of Conflict Resolution, Vol.
`45(6), p. 818–833, 2001 (with Lars–Erik Cederman).
`
`12. “Intellectual Property Protection Improves as India Implements the TRIPS
`Agreement,” India Business & Investment Report, June 2000.
`
`13. “TRIPS and Global Trade in Pharmaceuticals,” Working paper, UCLA, 2000.
`
`14. “Democratie et Commerce International,” Ar`es, Vol. XVIII(46), November
`2000 (with Michael D. Ward).
`
`15. “Intellectual Property Rights and Foreign Direct Investment,” Working paper,
`UCLA, 1998 (with Keith Maskus).
`
`16. “Indian Defense Expenditures in a Changed Global Security Environment.”
`International Studies, 1998.
`
`17. “The Strategic Design of Trade Policy Outcomes,” Working paper, UCLA, 1997
`(with Susanne Lohmann).
`
`6/7/2015
`
`Page 10 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 12 of 16 PageID #:
` 9155
`
`18. “Patents and International Trade: An Empirical Study.” In Robert M. Stern,
`Edward E. Leamer, and Keith E. Maskus, editors, Quiet Pioneering. Ann
`Arbor: University of Michigan Press, 1997 (with Keith E. Maskus).
`
`19. “Market Openness and Trade Conflict,” Working paper, UCLA, 1996.
`
`20. “How Trade–Related are Intellectual Property Rights?” Journal of Interna-
`tional Economics, Vol. 39, p. 227–248, 1995 (with Keith E. Maskus).
`
`21. “Guns and Growth Around the Globe.” International Interactions, Vol. 21(2),
`p. 181–201, 1995 (with Michael D. Ward et al).
`
`22. “North American Trade in the Post Debt Crises Era.” In Khosrow Fatemi,
`editor, North American Free Trade Agreement: Opportunities and Challenges.
`London: Macmillan, 1993, p. 84–97 (with Barry W. Poulson).
`
`23. “Canons et croissance dans le monde,” Ar`es, Vol. XIV(4), p. 15–31, 1993 (with
`Michael D. Ward).
`
`24. “Economic Growth, Investment, and Military Spending in India.” In Steve
`Chan and Alex Mintz, editors, Defense, Welfare, and Growth. London: Rout-
`ledge, 1992, p. 119—136 (with Michael D. Ward et al).
`
`25. “Military Spending in India.” Defence Economics, Vol. 3, p. 41–64, 1991 (with
`Michael D. Ward et al).
`
`Presentations and Speeches
`
`1. “The New World of Marketing and Finance,” Shirley Ryan Lecture Series on
`“Big Data: Impact On Our Lives,” Northwestern University, November 5, 2014.
`
`2. “Role of the Expert After Apple v. Motorola,” Litigating Patent Damages, Law
`Seminars International, San Francisco, May 29-30, 2014.
`
`3. “Dealing with Uncertainty of Damages and Injunctive Relief in the World of
`IP,” Annual Conference of the Association of Corporate Counsel, Wisconsin
`Chapter, Elkhart Lake, Wisconsin, May 9-10, 2013.
`
`4. “Game Theory Applications to BioPharma Deal Negotiations,” Annual Meet-
`ings of the Licensing Executives Society, Chicago, September 29, 2010.
`
`5. “Valuing Pharmaceutical and Biotechnology Pipelines,” a Professional Devel-
`opment Series Workshop at the Annual Meetings of the Licensing Executives
`Society, Chicago, September 26, 2010.
`
`6/7/2015
`
`Page 11 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 13 of 16 PageID #:
` 9156
`
`6. “Commercializing Technology Through the Power of IP Licensing,” a Profes-
`sional Development Series Course, Licensing Executives Society, Chicago, April
`26, 2010.
`
`7. “How to Value High Risk Early Stage Technologies,” Mornings@McCormick,
`Northwestern University, Evanston, April 13, 2010.
`
`8. “Valuation of Early Stage Pharmaceutical and Biotechnology Pipelines,” Work-
`shop at the Annual Meetings of the Licensing Executives Society, San Francisco,
`October 21, 2009.
`
`9. “Valuation, Taxation, and Pricing Issues with Intellectual Property,” Workshop
`at the Annual Meetings of the Licensing Executives Society, Orlando, October
`19, 2008.
`
`10. “Valuation of Early Stage Technologies,” Indian School of Business, Hyderabad,
`India, August 19, 2008.
`
`11. “Valuation of Intellectual Property,” 2nd Annual Patent Law Institute, Prac-
`tising Law Institute, New York, New York, January 14-15, 2008.
`
`12. “Economic Analysis in Class Actions,” Seminar on Innovative Strategies for
`Litigating Class Actions, Law Seminars International, Los Angeles, California,
`November 12–13, 2007.
`
`13. Recent Key Developments in Intellectual Property Law and Applicability at the
`Global Level, XPRT Forum, Sonoma, California, October 3-6, 2007.
`
`14. Effective Development and Presentation of Expert Testimony, Law Seminars
`International, Chicago, Illinois, September 24–25, 2007 (co-chair w/ Alan Sil-
`berman).
`
`15. “Intellectual Asset Management: Valuation,” a Professional Development Series
`Intermediate Course, Licensing Executives Society, Chicago, July 10, 2007.
`
`16. “Intellectual Asset Management: Advanced Valuation Skills,” a Professional
`Development Series Advanced Course, Licensing Executives Society, Philadel-
`phia, June 13–14, 2007.
`
`17. “Intellectual Asset Management: Valuation,” a Professional Development Se-
`ries Intermediate Course, Licensing Executives Society, Philadelphia, March 13,
`2007.
`
`18. “Intellectual Asset Management: Advanced Valuation Skills,” a Professional
`Development Series Advanced Course, Licensing Executives Society, San Fran-
`cisco, November 1–2, 2006.
`
`6/7/2015
`
`Page 12 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 14 of 16 PageID #:
` 9157
`
`19. “Implementing Valuation Methods,” a Professional Development Series Inter-
`mediate Workshop at the Annual Meetings of the Licensing Executives Society,
`New York, September 12, 2006.
`
`20. “Intellectual Asset Management: Valuation,” a Professional Development Series
`Intermediate Course, Licensing Executives Society, San Francisco, April 25,
`2006.
`
`21. Effective Development and Presentation of Expert Testimony, Law Seminars
`International, Chicago, Illinois, March 20–21, 2006 (co-chair w/ Alan Silber-
`man).
`
`22. “Lost Profits When the Patent is Only Part of the Whole,” Seminar on Calculat-
`ing and Proving Patent Damages, Law Seminars International, San Francisco,
`California, February 27–28, 2006.
`
`23. “The Use and Misuse of Statistics,” The American Institute of Certified Public
`Accountants, Jersey City, New Jersey, December 2, 2005.
`
`24. “Use of Statistics in IP Litigation” Presentation to McAndrews, Held & Malloy,
`Chicago, December 1, 2005.
`
`25. “Intellectual Asset Management: The Deal,” a Professional Development Se-
`ries Fundamentals Course, Licensing Executives Society, Arlington, Virginia,
`November 8-9, 2005.
`
`26. “Implementing Valuation Methods,” a Professional Development Series Inter-
`mediate Workshop at the Annual Meetings of the Licensing Executives Society,
`Phoenix, October 18, 2005.
`
`27. “Damages and Antitrust Issues in Intellectual Property Litigation” Presentation
`to Dykema Gossett, Chicago, July 21, 2005 (w/ Kathi Kedrowski).
`
`28. “Intellectual Asset Management: Valuation,” a Professional Development Series
`Intermediate Course, Licensing Executives Society, Chicago, July 19, 2005.
`
`29. “Implementing Valuation Methods,” a Professional Development Series Inter-
`mediate Workshop at the Annual Meetings of the Licensing Executives Society,
`Boston, October 17, 2004.
`
`30. “Use of Surveys and Statistics in Litigation,” Workshop at the Advanced Busi-
`ness Litigation Institute, Palm Springs, May 9, 2003.
`
`31. “Real Option Valuation,” Presented at the 2002 Winter Meeting of the Licensing
`Executives Society, Lake Las Vegas, February 14, 2002.
`
`6/7/2015
`
`Page 13 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 15 of 16 PageID #:
` 9158
`
`32. “Networked Computer Simulations,” CyberSpace@UCLA, UCLA Anderson Sch-
`ool of Management, Los Angeles, May 2, 2002.
`
`33. “Improving IP Financial Performance.” Presentation to Jones, Day, Reavis &
`Pogue, Los Angeles, June 20, 2001 (w/ David Haas).
`
`34. “Intellectual Property: The New Global Currency,” Jacob Marschak Collo-
`quium, UCLA Anderson School of Management, June 8, 2001.
`
`35. “Commerce and Democracy.” Presented at the conference on Spatial Analysis
`for Political Methodology, University of Colorado, Boulder, March 2000.
`
`36. “Determinants of International Trade Flows in an Era of Globalization.” Pre-
`sented at the UCLA Conference on International Institutions, Lake Arrowhead,
`February 2000.
`
`37. “Exploring the Dynamics of Interstate Conflict.” Presented at the Meetings of
`the International Studies Association, Des Moines, Iowa, October 1999.
`
`38. “Exploring the Dynamics of Interstate Conflict.” Presented at the UCLA Con-
`ference on Norms in International Relations, Los Angeles, October 1999.
`
`39. “Globalization and the Decline of Power Politics.” Presented at the Annual
`Meetings of the APSA, Atlanta, September 1999.
`
`40. “Inferring Micro– from Macrolevel Change.” Presented at the Annual Meetings
`of the MPSA, Chicago, April 1998 (with Alexander A. Schuessler).
`
`41. “Overtime Inference in Cross Sectional Surveys.” Presented at California Insti-
`tute of Technology, November 7, 1997.
`
`42. “Overtime Inference in Cross Sectional Surveys.” Presented at UCLA, October
`8, 1997.
`
`43. “Ecological Inference in Cross Sectional Surveys.” Presented at the Annual
`Meetings of the APSA, Washington, D.C., August 1997 (with Alexander A.
`Schuessler).
`
`44. “Governance in a Multinational World.” Presented at the Workshop on Global
`and Regional Governance, Institute of Global Conflict and Cooperation, UC
`San Diego, May 1997.
`
`45. “The Strategic Design of Trade Policy Outcomes: The Politics of Section 301.”
`Presented at the Annual Meetings of the APSA, San Francisco, August 1996
`(with Susanne Lohmann).
`
`6/7/2015
`
`Page 14 of 15
`
`

`
`Case 1:14-cv-00113-RGA-MPT Document 273-3 Filed 09/21/15 Page 16 of 16 PageID #:
` 9159
`
`46. “Polarization and Political Violence.” Presented at the Summer Methods Con-
`ference, Ann Arbor, Michigan, July 1996 (with Patrick Asea).
`
`47. “How Trade–Related are Intellectual Property Rights?” Presented at the In-
`ternational Economics Workshop, UCLA, April 3, 1996.
`
`48. “The Politics of Section 301: Institutional Design and Policy Outcomes.” Pre-
`sented at the Annual Meetings of the International Studies Association, San
`Diego, March 1996 (with Susanne Lohmann).
`
`49. “Military Spending in India.” Presented at the Conference on Security in South
`Asia, Jawaharlal Nehru University, New Delhi, January 1996.
`
`50. “Patents, Trade, and Foreign Direct Investment.” Presented at the Annual
`Meetings of the Allied Social Science Associations, San Francisco, January 1996
`(with Keith E. Maskus).
`
`51. “Forecasting the Collapse of the Soviet Union.” Presented at the Annual Meet-
`ings of the Peace Science Society International, Urbana–Champaign, November
`1994 (with Michael D. Ward).
`
`52. “Trade and Market Openness.” Presented at the International Colloquium on
`Defining a New Partnership Between North America and Europe, Institute of
`Behavioral Science, Boulder, July 1994.
`
`53. “Guns and Growth Around the World.” Presented at the Annual Meetings
`of the International Studies Association, Washington, D.C., March 1994 (with
`Michael D. Ward).
`
`54. “Trade and Patents: An Empirical Study.” Presented at the National Bureau
`of Economic Research Universities Research Conference on International Trade
`Rules and Institutions, Cambridge, December 1993 (with Keith E. Maskus).
`
`55. “The Trade Crises That Never Happened.” Presented at the 6th Hispanic
`Symposium on Business and the Economy, Boulder, October 1992 (with Barry
`W. Poulson).
`
`56. “Export Orientation and Economic Growth: Stylized Facts for Select Develop-
`ing Countries.” Presented at the Annual Meetings of the International Studies
`Association, Atlanta, April 1992 (with David R. Davis).
`
`6/7/2015
`
`Page 15 of 15